Parameter and Categories | Eligible Subjects with Evaluable IF Stained Cytology Slides | |||||
---|---|---|---|---|---|---|
All HV Subjects | All MBC Patients | |||||
N | > = 1 CTC | > = 5 CTC | N | > = 1 CTC | > = 5 CTC | |
All Patients | 72 | 5 (6.9%) | 2 (2.8%) | 75 | 34 (45.3%) | 18 (24.0%) |
Age at the time of the blood collection | ||||||
< 30 | 14 | 1 (7.1%) | 0 (0.0%) | 0 | 0 (0.0%) | 0 (0.0%) |
30—39 | 30 | 1 (3.3%) | 0 (0.0%) | 2 | 2 (100.0%) | 2 (100.0%) |
40—49 | 14 | 2 (14.3%) | 1 (7.1%) | 7 | 4 (57.1%) | 0 (0.0%) |
50—59 | 10 | 1 (10.0%) | 1 (10.0%) | 13 | 7 (53.8%) | 2 (15.4%) |
60—69 | 4 | 0 (0.0%) | 0 (0.0%) | 25 | 12 (48.0%) | 9 (36.0%) |
> = 70 | 0 | 0 (0.0%) | 0 (0.0%) | 28 | 9 (32.1%) | 5 (17.9%) |
Fisher’s Exact Test p -value | 0.610 | 0.307 | 0.288 | 0.034 | ||
Blood Collection Method | ||||||
Venipuncture | 72 | 5 (6.9%) | 2 (2.8%) | 32 | 8 (25.0%) | 3 (9.4%) |
Port | 0 | 0 (0.0%) | 0 (0.0%) | 43 | 26 (60.5%) | 15 (34.9%) |
Fisher’s Exact Test p -value | –- | –- | 0.003 | 0.014 | ||
Volume of Blood Processed | ||||||
≤ 8.0 mL | 21 | 0 (0.0%) | 0 (0.0%) | 17 | 4 (23.5%) | 3 (17.6%) |
8.5—9.0 mL | 30 | 3 (10.0%) | 1 (3.3%) | 23 | 13 (56.5%) | 8 (34.8%) |
9.5 mL | 15 | 2 (13.3%) | 1 (6.7%) | 23 | 12 (52.2%) | 5 (21.7%) |
≥ 10.0 mL | 6 | 0 (0.0%) | 0 (0.0%) | 12 | 5 (41.7%) | 2 (16.7%) |
Fisher’s Exact Test p -value | 0.334 | 0.754 | 0.180 | 0.628 | ||
Menopausal Status | ||||||
Pre-Menopausal | 54 | 3 (5.6%) | 1 (1.9%) | 7 | 4 (57.1%) | 2 (28.6%) |
Post-Menopausal | 15 | 1 (6.7%) | 1 (6.7%) | 65 | 29 (44.6%) | 16 (24.6%) |
Unknown | 3 | 1 (33.3%) | 0 (0.0%) | 3 | 1 (33.3%) | 0 (0.0%) |
Fisher’s Exact Test p -value | 0.249 | 0.440 | 0.874 | 1.000 | ||
Race | ||||||
White | 65 | 3 (4.6%) | 1 (1.5%) | 68 | 30 (44.1%) | 17 (25.0%) |
Black | 1 | 0 (0.0%) | 0 (0.0%) | 7 | 4 (57.1%) | 1 (14.3%) |
Other | 6 | 2 (33.3%) | 1 (16.7%) | 0 | 0 (0.0%) | 0 (0.0%) |
Fisher’s Exact Test p -value | 0.071 | 0.186 | 0.695 | 1.000 | ||
Smoking Status | ||||||
Never Smoked | 46 | 2 (4.3%) | 0 (0.0%) | 35 | 12 (34.3%) | 6 (17.1%) |
Previous Smoker | 23 | 3 (13.0%) | 2 (8.7%) | 35 | 18 (51.4%) | 10 (28.6%) |
Current Smoker | 2 | 0 (0.0%) | 0 (0.0%) | 5 | 4 (80.0%) | 2 (40.0%) |
Unknown | 1 | 0 (0.0%) | 0 (0.0%) | 0 | 0 (0.0%) | 0 (0.0%) |
Fisher’s Exact Test p -value | 0.417 | 0.158 | 0.113 | 0.326 | ||
Previous History of Cancer? | ||||||
Yes | 1 | 0 (0.0%) | 0 (0.0%) | 6 | 4 (66.7%) | 2 (33.3%) |
No | 71 | 5 (7.0%) | 2 (2.8%) | 69 | 30 (43.5%) | 16 (23.2%) |
Fisher’s Exact Test p -value | 1.000 | 1.000 | 0.401 | 0.626 | ||
Current Diagnosis of Hypertension? | ||||||
Yes | 4 | 0 (0.0%) | 0 (0.0%) | 41 | 14 (34.1%) | 8 (19.5%) |
No | 68 | 5 (7.4%) | 2 (2.9%) | 34 | 20 (58.8%) | 10 (29.4%) |
Fisher’s Exact Test p -value | 1.000 | 1.000 | 0.039 | 0.417 | ||
Current Diagnosis of High Cholesterol? | ||||||
Yes | 2 | 0 (0.0%) | 0 (0.0%) | 17 | 9 (52.9%) | 7 (41.2%) |
No | 70 | 5 (7.1%) | 2 (2.9%) | 58 | 25 (43.1%) | 11 (19%) |
Fisher’s Exact Test p -value | 1.000 | 1.000 | 0.582 | 0.103 | ||
Current Taking Growth Factors? | ||||||
Yes | 0 | 0 (0.0%) | 0 (0.0%) | 3 | 1 (33.3%) | 0 (0.0%) |
No | 72 | 5 (6.9%) | 2 (2.8%) | 72 | 33 (45.8%) | 18 (25.0%) |
Fisher’s Exact Test p -value | –- | –- | 1.000 | 1.000 | ||
Current Taking Anti-Coagulants? | ||||||
Yes | 1 | 1 (100.0%) | 1 (100.0%) | 13 | 6 (46.2%) | 2 (15.4%) |
No | 71 | 4 (5.6%) | 1 (1.4%) | 62 | 28 (45.2%) | 16 (25.8%) |
Fisher’s Exact Test p -value | 0.069 | 0.028 | 1.000 | 0.722 | ||
Current Taking Anti-Inflammatories? | ||||||
Yes | 4 | 1 (25.0%) | 1 (25.0%) | 35 | 17 (48.6%) | 9 (25.7%) |
No | 68 | 4 (5.9%) | 1 (1.5%) | 40 | 17 (42.5%) | 9 (22.5%) |
Fisher’s Exact Test p -value | 0.255 | 0.109 | 0.647 | 0.791 | ||
Current Taking Pain Medications? | ||||||
Yes | 3 | 0 (0.0%) | 0 (0.0%) | 48 | 27 (56.3%) | 15 (31.3%) |
No | 69 | 5 (7.2%) | 2 (2.9%) | 27 | 7 (25.9%) | 3 (11.1%) |
Fisher’s Exact Test p -value | 1.000 | 1.000 | 0.016 | 0.089 | ||
Current Taking Cytotoxic Therapies? | ||||||
Yes | 0 | 0 (0.0%) | 0 (0.0%) | 32 | 17 (53.1%) | 7 (21.9%) |
No | 72 | 5 (6.9%) | 2 (2.8%) | 43 | 17 (39.5%) | 11 (25.6%) |
Fisher’s Exact Test p -value | –- | –- | 0.348 | 0.789 | ||
Breast Cancer ER Status | ||||||
Positive | 0 | 0 (0.0%) | 0 (0.0%) | 65 | 29 (44.6%) | 13 (20.0% |
Negative | 0 | 0 (0.0%) | 0 (0.0%) | 9 | 4 (44.4%) | 4 (44.4%) |
Unknown | 0 | 0 (0.0%) | 0 (0.0%) | 1 | 1 (100.0%) | 1 (100.0%) |
Fisher’s Exact Test p -value | –- | –- | 0.849 | 0.073 | ||
Breast Cancer PR Status | ||||||
Positive | 0 | 0 (0.0%) | 0 (0.0%) | 55 | 26 (47.3%) | 10 (18.2%) |
Negative | 0 | 0 (0.0%) | 0 (0.0%) | 19 | 7 (36.8%) | 7 (36.8%) |
Unknown | 0 | 0 (0.0%) | 0 (0.0%) | 1 | 1 (100.0%) | 1 (100.0%) |
Fisher’s Exact Test p -value | –- | –- | 0.427 | 0.051 | ||
Breast Cancer HER2-neu Status | ||||||
Positive | 0 | 0 (0.0%) | 0 (0.0%) | 16 | 8 (50.0%) | 4 (25.0%) |
Equivocal | 0 | 0 (0.0%) | 0 (0.0%) | 7 | 4 (57.1%) | 4 (57.1%) |
Negative | 0 | 0 (0.0%) | 0 (0.0%) | 44 | 19 (43.2%) | 9 (20.5%) |
Unknown | 0 | 0 (0.0%) | 0 (0.0%) | 8 | 3 (37.5%) | 1 (12.5%) |
Fisher’s Exact Test p -value | –- | –- | 0.880 | 0.194 | ||
MBC Patient Disease Status | ||||||
Newly Diagnosed | 0 | 0 (0.0%) | 0 (0.0%) | 6 | 2 (33.3%) | 2 (33.3%) |
Stable / Responding | 0 | 0 (0.0%) | 0 (0.0%) | 44 | 18 (40.9%) | 10 (22.7%) |
Progressive / Recurrent | 0 | 0 (0.0%) | 0 (0.0%) | 25 | 14 (56.0%) | 6 (24.0%) |
Fisher’s Exact Test p-value | –- | –- | 0.453 | 0.770 |